Enalaprilat inhibits hydrogen peroxide production by murine mesangial cells exposed to high glucose concentrations

Nephrology Dialysis Transplantation

Volumn 12, Issue 3, 1997, Pages 456-464

  Ruiz Munoz L M ^a   Vidal Vanaclocha, F ^b   Lampreabe, I ^a  

^a HOSPITAL DE CRUCES   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Angiotensin converting enzyme; Diabetic nephropathy; Enalaprilat; High glucose; Hydrogen peroxide; Mesangial cell; Protein kinase C

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; FLUORESCENT DYE; GLUCOSE; HYDROGEN PEROXIDE; PROTEIN KINASE C; SARALASIN; STAUROSPORINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; FLUORESCENCE; KIDNEY CELL CULTURE; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; CELLS, CULTURED; ENALAPRILAT; GLOMERULAR MESANGIUM; GLUCOSE; HYDROGEN PEROXIDE; MICE;

EID: 0031044075     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.3.456     Document Type: Article

References (20)

1. Wardle EN. Cell biology and the functional changes of diabetic nephropathy. Nephrol Dial Transplant 1992; 7: 889-895
2. Kreisberg JI, Ayo SH. The glomerular mesangium in diabetes mellitus. Kidney Int 1993; 43: 109-113
3. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994; 74: 139-162
4. Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 1989; 35: 1093-1106
5. Andreoli SP. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol 1991; 5: 733-742
6. Stratta P, Canavese C, Dogliani M, Mazzucco G, Monga G, Vercellone A. The role of free radicals in the progression of renal disease. Am J Kidney Dis 1991; 27: 33-37
7. Wolff SP. Diabetes Mellitus and free radicals; Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 1993; 49: 645-652
8. Ha H, Yoon SJ, Kim KH. High glucose can induce lipid peroxidation in the isolated rat glomeruli. Kidney Int 1994; 46: 1620-1626
9. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD.The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462
10. Stefanski A, Amann K, Ritz E. To prevent progression: ACE inhibitors, calcium antagonists or both?. Nephrol Dial Transplant 1995; 10: 151-153
11. Rabkin SW. Cilazapril and captopril acelerate recovery from hypoxia in myocardial cell aggregates in culture. J Cardiovasc Pharmacol 1992; 19: 394-401
12. Bain SC, Le Guen CA, Lunec J. Comparison of the free radical scavenging activity of captopril versus enalapril: a three month in vivo study in hypertensive diabetic patients. J Hum Hypertens 1991; 5: 511-515
13. Kreisberg JI. Cell biology and biochemistry of the glomerular mesangium. Miner Electrolyte Metab 1988; 14: 167-175
14. Mené P, Simonson MS, Dunn MJ. Physiology of the mesangial cell. Physiol Rev 1989; 69: 1347-1424
15. Rosenkranz AR, Schmaldienst S, Stuhlmeier KM. A microplate assay for the detection of oxidative products using 2′7′dichlorofluorescein-diacetate . J Immunol Methods 1992; 156: 39-45
16. 2 production by hepatic sinusoidal endothelium in response to B16 melanoma cell adhesion. J Cell Physiol 1996; 167: 314-323
17. Giugliano D, Ceriello A, Paoliso G. Diabetes Mellitus, hypertension and cardiovascular disease; which role for oxidative stress? Metabolism 1995; 44: 363-368
18. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter T. The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 1994; 45: 403-410
19. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 1994; 45: 537-543
20. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous TGF-β. J Clin Invest 1993; 92: 1366-1373